Natixis Advisors L.P. Sells 53,060 Shares of Koninklijke Philips (NYSE:PHG)

Natixis Advisors L.P. lessened its holdings in shares of Koninklijke Philips (NYSE:PHG) by 6.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 838,201 shares of the technology company’s stock after selling 53,060 shares during the quarter. Natixis Advisors L.P.’s holdings in Koninklijke Philips were worth $19,555,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of PHG. Sequoia Financial Advisors LLC acquired a new position in shares of Koninklijke Philips during the 4th quarter worth about $473,000. HighTower Advisors LLC boosted its holdings in Koninklijke Philips by 73.9% in the 3rd quarter. HighTower Advisors LLC now owns 28,270 shares of the technology company’s stock valued at $562,000 after purchasing an additional 12,010 shares during the period. abrdn plc acquired a new stake in Koninklijke Philips in the 4th quarter worth $2,677,000. Barclays PLC bought a new position in shares of Koninklijke Philips during the 3rd quarter worth about $2,310,000. Finally, Glenmede Trust Co. NA raised its position in shares of Koninklijke Philips by 53.5% during the third quarter. Glenmede Trust Co. NA now owns 34,065 shares of the technology company’s stock valued at $679,000 after buying an additional 11,875 shares during the last quarter. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Trading Up 1.0 %

Shares of NYSE:PHG opened at $26.82 on Monday. The company has a 50 day moving average of $21.09 and a 200-day moving average of $21.21. The company has a current ratio of 1.20, a quick ratio of 0.78 and a debt-to-equity ratio of 0.58. Koninklijke Philips has a one year low of $17.75 and a one year high of $29.44.

Analyst Ratings Changes

A number of research firms recently weighed in on PHG. JPMorgan Chase & Co. raised Koninklijke Philips from an “underweight” rating to a “neutral” rating in a research report on Tuesday, April 30th. UBS Group raised Koninklijke Philips from a “sell” rating to a “neutral” rating in a research report on Tuesday, April 30th. StockNews.com upgraded shares of Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a research note on Thursday, February 8th. Finally, BNP Paribas lowered shares of Koninklijke Philips from an “outperform” rating to an “underperform” rating in a research report on Wednesday, February 7th. One analyst has rated the stock with a sell rating, two have given a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $19.00.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.